Annual Update event on the QbD Research Chair

The QbD Group has been actively supporting our research into glioblastoma ever since Pieter Van Vlierberghe, a close friend of QbD’s CEO Bart Van Acker, was diagnosed with the disease in 2020.

Pieter sadly lost his battle at the end of 2022. However, QbD remains dedicated to supporting the research in his honor and to helping future patients facing this devastating disease.

After an introduction by Bart Van Acker, Mark Peeters, CEO of UZA, presented on the future of healthcare, emphasizing patient-centered care. He discussed how technological advancements will increasingly allow patients to be monitored at home, which will require strong collaboration among multidisciplinary teams, home care providers, and caregivers.

As always, Researcher Yanti De Visser delivered a very accessible presentation on the importance of functional diagnostics. Following her, Professor Frederik De Smet provided an overview of the evolution of the LPCM (Laboratory for Precision Cancer Medicine) and highlighted the positive impact of QbD’s support.

To conclude the event, Hugo Van Puymbroeck, Pieter’s father-in-law, shared the story of his pilgrimage to Compostela. Accompanied by his friend Wim Waes, Hugo embarked on a journey of nearly 1000 kilometers, completed in 43 days. This feat was even more impressive considering Hugo is 75 years old and Wim is 84. Their journey raised an impressive €14,000, which they donated to brain tumor research.

Hugo’s presentation was a touching tribute to his son-in-law, and his story was a testament to the power of dedication and perseverance.

Thank you to everyone who joined us. See you next year!